Get started
222

APTABIO THERAPEUTICS INC.

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

293780 chart


Full chart

Key stats


Market capitalization
‪178.80 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−710 KRW
Net income (FY)
‪−12.06 B‬ KRW
Revenue (FY)
‪323.87 M‬ KRW
Shares float
‪16.15 M‬
Beta (1Y)
1.55

Employees


Employees (FY)
30
Change (1Y)
+9 +42.86%
Revenue / Employee (1Y)
‪8.29 K‬ KRW
Net income / Employee (1Y)
‪−308.78 K‬ KRW

About APTABIO THERAPEUTICS INC.


Sector
Health Technology
CEO
Su-Jin Lee
Headquarters
Yongin
Website
aptabio.com
Founded
2009
ISIN
KR7293780003
FIGI
BBG00P2BVY44
Aptabio Therapeutics, Inc. operates as a pharmaceutical biotechnology company that develops intractable innovative drugs based on original platform technology. It offers selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The company was founded by Su-Jin Lee on July 24, 2009 and is headquartered in Yongin, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 293780 is 6,750 KRW — it has decreased by −4.32% in the past 24 hours. Watch APTABIO THERAPEUTICS INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange APTABIO THERAPEUTICS INC. stocks are traded under the ticker 293780.
293780 stock has fallen by −15.39% compared to the previous week, the month change is a −18.70% fall, over the last year APTABIO THERAPEUTICS INC. has showed a −10.71% decrease.
293780 reached its all-time high on Sep 6, 2021 with the price of 62,100 KRW, and its all-time low was 4,930 KRW and was reached on May 27, 2024. View more price dynamics on 293780 chart.
See other stocks reaching their highest and lowest prices.
293780 stock is 4.15% volatile and has beta coefficient of 1.55. Track APTABIO THERAPEUTICS INC. stock price on the chart and check out the list of the most volatile stocks — is APTABIO THERAPEUTICS INC. there?
Today APTABIO THERAPEUTICS INC. has the market capitalization of ‪179.09 B‬, it has decreased by −8.02% over the last week.
Yes, you can track APTABIO THERAPEUTICS INC. financials in yearly and quarterly reports right on TradingView.
293780 net income for the last quarter is ‪−7.03 B‬ KRW, while the quarter before that showed ‪−3.97 B‬ KRW of net income which accounts for −77.29% change. Track more APTABIO THERAPEUTICS INC. financial stats to get the full picture.
No, 293780 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 13, 2024, the company has 30.00 employees. See our rating of the largest employees — is APTABIO THERAPEUTICS INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. APTABIO THERAPEUTICS INC. EBITDA is ‪−17.12 B‬ KRW, and current EBITDA margin is ‪−5.05 K‬%. See more stats in APTABIO THERAPEUTICS INC. financial statements.
Like other stocks, 293780 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APTABIO THERAPEUTICS INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So APTABIO THERAPEUTICS INC. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating APTABIO THERAPEUTICS INC. stock shows the sell signal. See more of APTABIO THERAPEUTICS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.